NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine (Q2878453): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 40.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 767,573.44 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 307,029.38 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
40.0 percent
| |||||||||||
| Property / co-financing rate: 40.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 17:36, 4 November 2022
Project Q2878453 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NETDIAMOND: New targets in diastolic heart failure: From comorbidities to personalised medicine |
Project Q2878453 in Portugal |
Statements
307,029.38 Euro
0 references
767,573.44 Euro
0 references
40.0 percent
0 references
1 December 2016
0 references
30 June 2021
0 references
UNIVERSIDADE DO PORTO
0 references
Q2993198 (Deleted Item)
0 references
Identifiers
LISBOA-01-0145-FEDER-016385
0 references